<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="35322">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02137720</url>
  </required_header>
  <id_info>
    <org_study_id>1R18DK098742-01A1</org_study_id>
    <secondary_id>1R18DK098742-01A1</secondary_id>
    <nct_id>NCT02137720</nct_id>
  </id_info>
  <brief_title>Translating Telephonic Diabetes Self-management Support to Primary Care Practice</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Albert Einstein College of Medicine of Yeshiva University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>New York City Department of Health and Mental Hygiene</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Albert Einstein College of Medicine of Yeshiva University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <authority>United States: The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to evaluate the implementation and effectiveness of an
      intervention to improve diabetes self-management, emotional distress and metabolic control
      among adults with type 2 diabetes receiving care in primary care practices throughout New
      York City. The program will be implemented by the New York City Department of Health,
      through their Primary Care Improvement Project.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2014</start_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>HbA1c</measure>
    <time_frame>Change from baseline at 12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Obtained from electronic medical record.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diabetes Self-Management</measure>
    <time_frame>Change from baseline at 12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measured by self-report questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication Adherence</measure>
    <time_frame>Change from baseline at 12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measured by self-report questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes-related distress</measure>
    <time_frame>Change from baseline at 12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measured by self-report questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depressive symptoms</measure>
    <time_frame>Change from baseline at 12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measured by self-report questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Baseline and 12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Obtained from electronic medical record.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cholesterol</measure>
    <time_frame>Baseline and 12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Obtained from electronic medical record.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">875</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Telephonic Diabetes Self-Management Support</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group receives all the Educational Print Materials received by the comparison condition plus telephone calls from a health educator to provide tailored diabetes self-management training and support. Participants with significant emotional distress at baseline also receive additional calls focused on distress management.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Educational Print Materials</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants randomized to this arm will receive print materials on diabetes, glycemic control, self-management, and distress/depression.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Telephonic Diabetes Self-Management Support</intervention_name>
    <arm_group_label>Telephonic Diabetes Self-Management Support</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Educational Print Materials</intervention_name>
    <arm_group_label>Educational Print Materials</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  21 years of age and older

          -  Receiving treatment for diabetes at selected primary care practices throughout New
             York City

          -  Most recent HbA1c â‰¥ 7.5% (max 3 months prior to randomization)

          -  Ability to speak and read English or Spanish (or someone in the household who will
             read to them)

          -  Access to a telephone

          -  Willing to give informed consent to participate and accept random assignment.

        Exclusion Criteria:

          -  Stated intention to move out of the New York City area during the next year

          -  Mental incapacity (e.g., confusion) evident on first telephone contact by Department
             of Health staff

          -  Treatment provider deems that the patient is inappropriate for the trial
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey S Gonzalez, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Albert Einstein College of Medicine of Yeshiva University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Winfred Y Wu, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York City Department of Health and Mental Hygiene</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Winfred Y Wu, MD, MPH</last_name>
    <phone>347-396-4916</phone>
    <email>wwu2@health.nyc.gov</email>
  </overall_contact>
  <location>
    <facility>
      <name>New York City Department of Health and Mental Hygiene</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>11101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 9, 2014</lastchanged_date>
  <firstreceived_date>May 8, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Albert Einstein College of Medicine of Yeshiva University</investigator_affiliation>
    <investigator_full_name>Jeffrey Gonzalez</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Treatment Adherence</keyword>
  <keyword>Self-management</keyword>
  <keyword>Emotional Distress</keyword>
  <keyword>Diabetes-related Distress</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
